Femasys receives CE Mark for four women's health products, enters EU market

FEMASYS INC

Received EU MDR certificate and CE Mark for FemaSeed, FemVue, FemCerv, FemCath.
Approvals allow Femasys to begin marketing all four products in the European Union.
CEO Kathy Lee-Sepsick: CE Mark validates commitment to highest quality and safety standards.
Company will identify strategic distribution partners to commercialize products throughout the EU.
Initial US commercial team build-out completed; EU expansion follows CE Mark approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.